Navigation Links
Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise
Date:5/15/2008

ROCKVILLE, Md., May 15 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that Kevin P. McRaith has joined the Company as Vice President, Hepatology Franchise. Mr. McRaith, formerly Vice President, Sales & Marketing - Hematology, Genentech Corporation, will report to Barry A. Labinger, Executive Vice President and Chief Commercial Officer.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )

"Kevin McRaith brings to HGS a wealth of experience and an established record of accomplishment in the successful commercialization of products in a number of therapeutic areas," said Mr. Labinger. "I am excited to have Kevin join our senior management team to play a key role in our efforts to build a world class commercial organization. As head of our Hepatology Franchise, Kevin will have responsibility for all marketing and sales activities for Albuferon, including leading our preparation for launch and managing the overall performance of our Albuferon business."

Mr. McRaith has more than 20 years of experience commercializing therapies for infectious diseases, oncology, neurological diseases and cardiology. As Vice President, Sales and Marketing for Genentech's Hematology Franchise, he led the commercial efforts for the top-selling biologic, Rituxan (rituximab). Prior to joining Genentech in 2005, Mr. McRaith served with Abbott Laboratories for 15 years, where he held a number of senior positions with responsibility for managing major product franchises, directing marketing and sales activities, and leading a number of successful launches. Before joining Abbott in 1990, he spent several years in sales and
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Volcano Corp Announces First Human Use of the Volcano Optical Coherence Tomography (OCT) Imaging Catheter
2. Human Genome Sciences Announces First Quarter 2008 Financial Results and Key Developments
3. Pioneer(R) Surgical Technology Announces First Human Implants of its NuNec(TM) Cervical Arthroplasty Device
4. China Biologic Products Announces SFDA Approval for the Production of Cryoprecipitate and for the Clinical Trial of Human Prothrombin Complex
5. Human Genome Sciences to Sponsor Conference Call to Discuss First Quarter 2008 Financial Results
6. Identity Sciences Introduces a New, Fast Forensic Human I.D. Test
7. Human Genome Sciences Advances Oncology Portfolio
8. AMDL Signs Exclusive Licensing Agreement for Human Papilloma Virus Diagnostic Test Kit in Certain Asian Countries
9. Human Pheromone Sciences Announces Quarterly and Full Year Results
10. CryoLife Announces Implant of First FDA-Cleared SynerGraft(R) Processed Human Pulmonary Heart Valve
11. Oregon Health Care Quality Corporation Receives Important Designation from U.S. Department of Health and Human Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... (PRWEB) May 21, 2013 Through science ... and funds for lab equipment, 25 organizations will continue ... importance of optics and photonics in daily life with ... , The organizations, located in 10 countries, are the ... be awarded by SPIE, the international society for ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 ... services company for clinical trials, announced today it ... Solutions, LLC. Clinverse’s ClinPay® FLS eClinical commerce ... payment process. SpendMD ™, Aggregate Spend ... solution for tracking and reporting transfer of value ...
(Date:5/21/2013)... Emerson Resources Inc. , a premier ... the Company’s Chief Executive Officer and Chairman of the ... of service. As part of Emerson Resources’ planned leadership ... named as Dr. Signorino’s successor. , Dr. Signorino ... made a significant contribution to the field during his ...
(Date:5/21/2013)... Revolutionary Science, the manufacturer of the IncuCount ... they have expanded their colony counter product line to ... and ImpressCount. These affordable colony counters that range ... microbiology and pharmaceutical manufacturing. , The previously released IncuCount ... white enclosure with jet black accents represent the updated ...
Breaking Biology Technology:Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3Emerson Resources Announces CEO Retirement and Appointment of Successor 2Emerson Resources Announces CEO Retirement and Appointment of Successor 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2
... 23, 2011 BioDrain Medical, Inc. (OTC Bulletin Board: ... Streamway® System for automated surgical fluid disposal, announced today ... Number 2,495,747 – for the Company,s Streamway System "for ... workers." The patent was granted to the Company in ...
... , MADISON In the computer displays of medical ... already found a major role. But a discovery reported ... of liquid crystal, which have been found to change ... presence of very low concentrations of a particular bacterial ...
... 2011 Today, the United States District Court for ... plaintiffs Cephalon, Inc. (NASDAQ: CEPH ), and ... Mylan Pharmaceuticals Inc., and Mylan Inc., from manufacturing, using, ... capsules, a generic version of Cephalon,s branded product AMRIX®. ...
Cached Biology Technology:BioDrain Medical, Inc. Granted Canadian Patent for its Streamway® Surgical Fluid Management System 2BioDrain Medical, Inc. Granted Canadian Patent for its Streamway® Surgical Fluid Management System 3Liquid crystal droplets discovered to be exquisitely sensitive to an important bacterial lipid 2Liquid crystal droplets discovered to be exquisitely sensitive to an important bacterial lipid 3Cephalon Granted Temporary Restraining Order in AMRIX® Patent Litigation 2Cephalon Granted Temporary Restraining Order in AMRIX® Patent Litigation 3
(Date:5/21/2013)... a class of pharmaceuticals can both prevent and treat ... as "TSPO ligands," are currently used for certain types ... TSPO ligand in young adult mice when pathology was ... pathology was quite severe," said lead researcher Christian Pike ... reduced measures of pathology and improved behavior at both ...
(Date:5/21/2013)... Researchers at the University of Illinois at Chicago College of ... and stores fat -- its main energy source -- and ... disease, under a new $2 million, 4-year grant from the ... heart changes how it uses fuel for energy. These changes ... disease and are different in men and women, says E. ...
(Date:5/21/2013)... scientists have charted the path of insulin action in ... a comprehensive blueprint for understanding what goes wrong in ... Humphrey and Professor David James from Sydney,s Garvan Institute ... online edition of the prestigious journal Cell Metabolism ... plays a very important role in the body because ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2Do men's and women's hearts burn fuel differently? 2Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3
... six thousand years in estuary sedimentation records to look ... published in Global Change Biology , show an ... 60 years. This shift could diminish the ability of ... climate change. According to Dr. Peter Macreadie, University ...
... to understand the effect of ageing on the immune ... Biological Sciences Research Council (BBSRC) announced investment in a ... be led by researchers from the Babraham Institute with ... Laboratory of Molecular Biology. The team hopes to illuminate ...
... springtime but, viewed under the microscope, a pollen grain ... pollen are part of an exhibition at CSIRO Discovery ... The exhibition ,Pollen Under the Microscope, celebrates the ... and speed up our understanding of nature. It ...
Cached Biology News:New research aims to shed light on how aging affects immunity 2New research aims to shed light on how aging affects immunity 3Pollen research not be sniffed at 2
Form: Ready to use Applications: ELISA...
RABBIT ANTI HALOPERIDOL...
Form: Ready to use Applications: ELISA...
Form: Ready to use Applications: Western Blot, ELISA...
Biology Products: